ES2152322T3 - Composicion de sulfato de colistina estabilizada. - Google Patents

Composicion de sulfato de colistina estabilizada.

Info

Publication number
ES2152322T3
ES2152322T3 ES94919820T ES94919820T ES2152322T3 ES 2152322 T3 ES2152322 T3 ES 2152322T3 ES 94919820 T ES94919820 T ES 94919820T ES 94919820 T ES94919820 T ES 94919820T ES 2152322 T3 ES2152322 T3 ES 2152322T3
Authority
ES
Spain
Prior art keywords
colistine
composition
sulphate
staisted
stabilized
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94919820T
Other languages
English (en)
Inventor
Toshiyuki Nakata
Noboru Takaoka
Masamoto Iizuka
Yoshiaki Okabe
Motoharu Pharma-Tech Kinoshita
Yoshio Komatsu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meiji Seika Kaisha Ltd
Original Assignee
Meiji Seika Kaisha Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Seika Kaisha Ltd filed Critical Meiji Seika Kaisha Ltd
Application granted granted Critical
Publication of ES2152322T3 publication Critical patent/ES2152322T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/195—Antibiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K40/00—Shaping or working-up of animal feeding-stuffs
    • A23K40/10—Shaping or working-up of animal feeding-stuffs by agglomeration; by granulation, e.g. making powders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Fodder In General (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

SE PRESENTA UNA NUEVA COMPOSICION ESTABILIZADA QUE CONTIENE SULFATO DE COLISTINA COMO INGREDIENTE ACTIVO, COMPUESTA DE UNA MEZCLA DE MICROPARTICULAS DE SULFATO DE COLISTINA Y MICROPARTICULAS DE {BE} LA FASE CONTINUA DE {AL} PARTICULAS DE COMPOSITO DE DICHA MEZCLA TIENEN UN ALCANCE DIMENSIONAL DE LAS PARTICULAS PARTICULAR. EL COMPONENTE DE SULFATO DE COLISTINA DE ESTA COMPOSICION SE ESTABILIZA PARA QUE NO SE DEGRADE E INACTIVA A UN NIVEL BAJO INADMISIBLE, INCLUSO CUANDO ESTA COMPOSICION SE HA MEZCLADO CON UN PRODUCTO DE ALIMENTACION MEZCLADO, Y SE CONFORMA DESPUES A MODO DE BOLITAS MEDIANTE UNA COMPRESION A ALTA TEMPERATURA DE 120 (GRADOS) C EN PRESENCIA DE VAPOR DE AGUA CALIENTE.
ES94919820T 1994-06-29 1994-06-29 Composicion de sulfato de colistina estabilizada. Expired - Lifetime ES2152322T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP1994/001054 WO1996000506A1 (en) 1994-06-29 1994-06-29 Stabilized composition comprising colistin sulfate

Publications (1)

Publication Number Publication Date
ES2152322T3 true ES2152322T3 (es) 2001-02-01

Family

ID=14098469

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94919820T Expired - Lifetime ES2152322T3 (es) 1994-06-29 1994-06-29 Composicion de sulfato de colistina estabilizada.

Country Status (8)

Country Link
EP (1) EP0804088B1 (es)
JP (1) JP3345652B2 (es)
KR (1) KR100337978B1 (es)
DE (1) DE69426211T2 (es)
DK (1) DK0804088T3 (es)
ES (1) ES2152322T3 (es)
PT (1) PT804088E (es)
WO (1) WO1996000506A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5767068A (en) * 1997-02-13 1998-06-16 Pathogenesis Corporation Pure biologically active colistin, its components and a colistin formulation for treatment of pulmonary infections
CN1192795C (zh) * 1999-12-14 2005-03-16 旭化成制药株式会社 硫酸粘杆菌素颗粒
JP2001278806A (ja) * 2000-03-31 2001-10-10 Kaken Pharmaceut Co Ltd 硫酸コリスチン安定化製剤
EP2218336A1 (en) 2009-01-30 2010-08-18 Andersen S.A. Process for the preparation of colistin medicated feeds and feeds obtainable by said process
KR101879197B1 (ko) * 2012-04-27 2018-08-17 니혼 콘 스타치 가부시키가이샤 전분 과립의 제조 방법 및 구강 내 붕괴정
RS60874B1 (sr) * 2014-10-03 2020-11-30 Xellia Pharmaceuticals Aps Kompozicije

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5438163B2 (es) * 1972-01-24 1979-11-19
GB1349620A (en) * 1972-10-12 1974-04-10 Scient Feed Lab Co Ltd Process for preparing granules of materials for blending into a mixed feed or premix
FR2302084A1 (fr) * 1974-07-02 1976-09-24 Roussel Uclaf Nouveau sel d'erythromycine, son procede de preparation et son application a titre de medicament
JPS59187744A (ja) * 1983-04-08 1984-10-24 Ueno Seiyaku Oyo Kenkyusho:Kk 養魚用顆粒製剤
JPS60132987A (ja) * 1983-12-22 1985-07-16 Riken Vitamin Co Ltd クロロフイル組成物
SI8511997A8 (en) * 1985-12-19 1996-06-30 Krka Tovarna Zdravil Process for preparation of composition of zn-salt of bacitracine
IT1229194B (it) * 1989-03-03 1991-07-25 Ind Italiana Integratori Trei Matrici protettive a rilascio controllato per uso zootecnico e veterinario.
JPH053759A (ja) * 1991-06-28 1993-01-14 Asahi Chem Ind Co Ltd 飼料添加物用コリスチン製剤
JPH05168421A (ja) * 1991-12-24 1993-07-02 Kaken Pharmaceut Co Ltd 硫酸コリスチン含有飼料用安定化製剤
JP2941585B2 (ja) * 1992-12-24 1999-08-25 明治製菓株式会社 コリスチン安定化製剤

Also Published As

Publication number Publication date
DE69426211T2 (de) 2001-05-17
DE69426211D1 (de) 2000-11-30
KR970703711A (ko) 1997-08-09
EP0804088B1 (en) 2000-10-25
DK0804088T3 (da) 2000-11-20
WO1996000506A1 (en) 1996-01-11
EP0804088A1 (en) 1997-11-05
JP3345652B2 (ja) 2002-11-18
JPH10501982A (ja) 1998-02-24
PT804088E (pt) 2001-02-28
KR100337978B1 (ko) 2002-10-11

Similar Documents

Publication Publication Date Title
BR9908877A (pt) Produto alimentìcio de multicomponentes e método para produzir e usar o mesmo
ES2174920T3 (es) Producto de combinacion para la contracepcion que contiene agentes antagonistas de progesterona y un agente gestageno.
BR0215052A (pt) Composições acaricidas e métodos
BR9913462A (pt) Trava de peça única para bainha divisìvel
BR0011643A (pt) Artigos absorventes incorporando gráficos que mudam de cor
BR9906287A (pt) Bactéria pertencente ao gênero escherichia e que tem uma capacidade para produzir um l-aminoácido, e, processo para produzir um l-aminoácido
AR018109A1 (es) FORMULACIoN GALÉNICA ADMINISTRABLE POR VíA ORAL QUE PERMITE UNA ABSORCIoN MEJORADA DE PRINCIPIOS ACTIVOS, USO DE UN AGENTE MAJORADOR DE ABSORCIoN PARA PREPARAR UNA FORMA DE DOSIFICACIoN ADMINISTRABLE POR VíA ORAL Y PROCEDIMIENTO PARA PREPARAR DICHA FORMULACIoN GALÉNICA
ES2189768T3 (es) Sintesis regioselectiva de derivados de rapamicina.
ES2152367T3 (es) Composiciones fertilizantes en emulsion agua en aceite.
ES2141486T3 (es) Fertilizante y procedimiento de preparacion del mismo.
ES2152322T3 (es) Composicion de sulfato de colistina estabilizada.
BR0214706A (pt) Estrutura absorvente envolta
BR9809571A (pt) Composição medicinal e processo para produzì-la
JPS53145932A (en) Stable aromatic gel containing perfume
JPS539739A (en) #-trifluoromethyl-##-isoproxybenzoic acid anilide, its preparation and its use
JP2002536304A5 (es)
MY121109A (en) Composition.
BR0314804A (pt) Forma de dosagem de liberação modificada
JPS55141181A (en) Production of germ-free potage soup
SU1684978A1 (ru) Протез тела позвонка
BR9912278A (pt) Artigos absorventes descartáveis com absorção e retenção de lìquido aperfeiçoados
JPS5683418A (en) Fomentation
Videman An experimental study of the effects of growth on the relationship of tendons and ligaments to bone at the site of diaphyseal insertion. I. Experiments with 35S-sulphate and oxytetracycline
JPS543547A (en) Corona discharger
Patient In the January 1996 article" Decreased Cortical and Increased Cancellous Bone in Two Children With Primary Hyperparathyroidism" by Boechat et al (Metabolism 45: 76-81, 1996), the graph in Fig 6 depicted only changes on cancellous bone. The correct graph, depicting changes on cancellous and cortical bone, is shown below.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 804088

Country of ref document: ES